Nanjing Leads Biolabs receives Chinese approval for pivotal Phase III trial of PD-L1/4-1BB bispecific antibody

CelLBxHealth partners with AdventHealth on cancer monitoring studies

GSK's Arexvy gains expanded approval in Japan for at-risk adults aged 18-49

SN BioScience reports first patient dosed in global Phase 1b/2 clinical trial of SNB-101

SOPHiA GENETICS and Synnovis partner to expand NHS liquid biopsy testing

Ranok Therapeutics reports positive Phase 1a clinical results for KRAS G12D inhibitor RNK08954

Innovent's IBI363 receives third Chinese regulatory BTD for MSS/pMMR CRC

European Commission approves Bristol Myers Squibb's Sotyktu for psoriatic arthritis

Chance Pharma reports NMPA acceptance of NDA for investigational respiratory drug CXG87

Racura Oncology identifies mechanism of action for (E,E)-bisantrene

Insilico's Rentosertib inhalation solution receives IND clearance to enter direct-to-lung clinical study

Xcovery and EVERSANA partner for US commmercialisation of lung cancer drug Ensacove

Cipla's AB-rated Ventolin HFA generic receives US FDA approval

Orion Pharma launches Phase 1b/2 TEADCO trial of ODM-212 in advanced solid tumours

Natera showcases Prospera transplant data across 17 presentations at ISHLT 2026